Daily Anesthesiology Research Analysis
Three anesthesia-relevant studies stand out today: a network meta-analysis of 85 trials (n=18,981) identifies anti-inflammatory strategies (NSAIDs, statins) that probably reduce postoperative atrial fibrillation after cardiac surgery; a randomized trial shows propofol deep sedation with intravenous paracetamol is as effective as fentanyl but with fewer respiratory events during colonoscopy; and a prospective cohort demonstrates airway ultrasound metrics improve prediction of difficult mask venti
Summary
Three anesthesia-relevant studies stand out today: a network meta-analysis of 85 trials (n=18,981) identifies anti-inflammatory strategies (NSAIDs, statins) that probably reduce postoperative atrial fibrillation after cardiac surgery; a randomized trial shows propofol deep sedation with intravenous paracetamol is as effective as fentanyl but with fewer respiratory events during colonoscopy; and a prospective cohort demonstrates airway ultrasound metrics improve prediction of difficult mask ventilation.
Research Themes
- Perioperative arrhythmia prevention after cardiac surgery
- Opioid-sparing sedation strategies and respiratory safety
- Airway ultrasound for difficult mask ventilation prediction
Selected Articles
1. Effectiveness of Anti-Inflammatory Agents to Prevent Atrial Fibrillation After Cardiac Surgery: A Systematic Review and Network Meta-Analysis.
Across 85 trials (n=18,981), NSAIDs and statins probably reduce new-onset POAF after cardiac surgery without affecting mortality or serious adverse events. Fish oil with vitamins C/E, colchicine, corticosteroids, and N-acetylcysteine may also help, but with lower certainty.
Impact: Identifies practical, widely available pharmacologic options that can be integrated into perioperative care pathways to prevent POAF. The large evidence base and GRADE assessment strengthen credibility for guideline updates.
Clinical Implications: Consider incorporating NSAIDs or statins into perioperative protocols for cardiac surgery patients at risk of POAF, while balancing bleeding, renal, or hepatic risks. Routine use should be individualized and aligned with cardiology/anesthesiology teams.
Key Findings
- NSAIDs reduced POAF risk vs placebo: RR 0.37 (95% CI 0.23–0.59), moderate certainty.
- Statins reduced POAF risk vs placebo: RR 0.56 (95% CI 0.45–0.70), moderate certainty.
- Fish oil + vitamins C/E (RR 0.30), colchicine (RR 0.62), corticosteroids (RR 0.70), and N-acetylcysteine (RR 0.69) may reduce POAF with low certainty; no effect on mortality or serious adverse events.
Methodological Strengths
- Frequentist random-effects network meta-analysis with ROB 2.0 risk-of-bias and GRADE certainty assessments
- Large evidence base: 85 RCTs with 18,981 participants across multiple drug classes
Limitations
- Certainty for several agents (e.g., fish oil+vitamins, colchicine, corticosteroids, NAC) was low
- Heterogeneity in dosing, timing, and patient selection; no mortality benefit detected
Future Directions: Head-to-head pragmatic RCTs comparing NSAID and statin strategies, safety profiling (bleeding, renal), and integration into ERAS pathways; biomarker-driven risk stratification for POAF prevention.
BACKGROUND: Preventing postoperative atrial fibrillation (POAF) as one of the most significant complications of cardiovascular surgeries remains a major clinical challenge. We conducted a systematic review with network meta-analysis of randomized controlled trials, to identify the most effective and safe anti-inflammatory drugs to prevent new-onset POAF. METHODS: MEDLINE, Embase, Web of Science, and Cochrane Library were searched without language or publication-date restriction on August 8, 2022 (updated on August 8, 2023). We assessed the risk of bias of included trials using the Cochrane risk-of-bias 2.0 tool. We conducted a frequentist random-effects network meta-analysis in R, and we assessed the certainty of evidence using the Grading of Recommendations, Assessment, Development, and Evaluations (GRADE) approach. RESULTS: A total of 85 trials reported the incidence of new-onset POAF, including 18,981 patients. Use of nonsteroidal anti-inflammatory drugs (relative risk [RR] 0.37 [95% confidence interval [CI] 0.23-0.59]) and statins (RR 0.56 [95% CI 0.45-0.7]) potentially reduced the risk of POAF compared with placebo (both with a moderate certainty level). Use of fish oil in combination with vitamins C and E (RR 0.30 [95% CI 0.13-0.68]) may reduce the risk of POAF, compared with placebo (low level of certainty). Use of colchicine (RR 0.62 [95% CI 0.45- 0.85]), corticosteroids (RR 0.70 [95% CI 0.59-0.82]) and N-acetylcysteine (RR 0.69 [95% CI 0.49- 0.98]) may reduce the risk of POAF (all with a low level of certainty). None of the interventions had a significant effect on mortality rate or risk of serious adverse effects. CONCLUSIONS: Use of nonsteroidal anti-inflammatory drugs and statins probably are effective in preventing new-onset POAF, with a moderate level of certainty, compared to placebo.
2. Clinical Efficacy Between Intravenous Paracetamol and Intravenous Fentanyl for Propofol Deep Sedation in Colonoscopy: A Randomized Controlled Trial.
In 225 adults undergoing colonoscopy with propofol deep sedation, IV paracetamol achieved similar procedural success and satisfaction as IV fentanyl, but with fewer intra-procedural airway obstructions and desaturation events. No serious complications occurred.
Impact: Supports an opioid-sparing adjunct for deep sedation that may improve respiratory safety without compromising efficacy, informing sedation protocols in endoscopy units.
Clinical Implications: Consider IV paracetamol as an alternative to fentanyl when using propofol deep sedation for colonoscopy, particularly in patients at risk of airway obstruction or hypoxemia.
Key Findings
- Procedural success, satisfaction, tolerance, and ease were similar between IV paracetamol and IV fentanyl groups.
- Fentanyl group had significantly more upper airway obstruction and oxygen desaturation during the procedure.
- No serious complications in either group; trial was prospectively registered (TCTR 20190321002).
Methodological Strengths
- Randomized controlled design with prospective trial registration
- Standardized deep sedation protocol with propofol and premedication
Limitations
- Single-center study; generalizability may be limited
- Not designed to quantify rare adverse events or long-term outcomes
Future Directions: Multicenter trials to confirm respiratory safety benefits, dose-optimization studies, and cost-effectiveness analyses for opioid-sparing sedation pathways.
INTRODUCTION: Sedation practices for colonoscopy indeed vary widely around the globe. Due to a lack of data on intravenous paracetamol, we aimed to investigate the clinical efficacy of intravenous paracetamol compared to intravenous fentanyl under propofol deep sedation for colonoscopy. METHODS: A total of 225 patients who underwent colonoscopy at Siriraj Hospital were randomly assigned to two groups. All patients underwent deep sedation with propofol and received intravenous (iv) paracetamol (group P, n = 113) or iv fentanyl (group F, n = 112). All patients received a premedication of 0.02-0.03 mg/kg of midazolam intravenously. Fifteen to thirty minutes before the procedure, patients in group P were administered 1000 mg of iv paracetamol, while those in group F received 0.001 mg/kg of iv fentanyl. All patients were oxygenated with 100% O RESULTS: All colonoscopies were successfully completed. There were no significant differences in patient characteristics, duration of the procedure, endoscopist and patient satisfaction, patient tolerance, or ease of the procedure between the two groups. However, group F experienced significantly higher rates of upper airway obstruction and oxygen desaturation during the procedure compared to group P. No serious complications were observed in either group. CONCLUSION: Intravenous paracetamol with propofol deep sedation in adult patients is non-inferior to intravenous fentanyl for successful colonoscopy completion. Sedation-related complications were relatively lower in the propofol deep sedation with iv paracetamol group compared to the propofol deep sedation with iv fentanyl group. REGISTRATION: This trial was registered with the Thai Clinical Trial Registry (TCTR 20190321002).
3. Prediction of difficult mask ventilation in Thai adult patients undergoing elective surgery using ultrasound of distance from skin to hyoid bone, and from skin to thyroid isthmus: a prospective cohort observational study.
In 189 Thai adults, preoperative airway ultrasound measurements (DSHB and DSTI) significantly discriminated difficult mask ventilation when combined with clinical factors, achieving an AUC of 0.89. Male sex, Mallampati III, edentulousness, DSHB, and DSTI were independent predictors.
Impact: Provides practical ultrasound-based metrics to enhance preoperative risk stratification for mask ventilation, directly informing airway management and resource allocation.
Clinical Implications: Incorporate DSHB and DSTI ultrasound into preoperative airway assessment, especially in patients with Mallampati III, male sex, or edentulousness, to anticipate the need for additional personnel or adjuncts.
Key Findings
- DSHB differed significantly across DMV categories (p<0.001); DSTI also differed (p=0.041).
- Independent predictors of DMV-III: male sex, modified Mallampati III, edentulousness, DSHB, and DSTI; model AUC 0.89.
- No DMV-IV cases; majority were DMV-I (67%).
Methodological Strengths
- Prospective cohort with predefined ultrasound measurements and multivariable modeling
- Use of Han’s standardized mask ventilation classification
Limitations
- Single-center Thai cohort limits generalizability; no DMV-IV events observed
- Ultrasound metrics alone are insufficient; requires combination with clinical factors
Future Directions: External validation in diverse populations, threshold optimization for DSHB/DSTI, and integration into comprehensive airway risk scores and training curricula.
BACKGROUND: A previous study showed that airway ultrasound, specifically the distance from the skin to the hyoid bone (DSHB), may be correlated with a higher risk of difficult mask ventilation (DMV). However, the study was conducted in Italy and lacks data for the Asian and Thai populations. This study aimed to predict DMV using pre-operative ultrasonography to measure the DSHB and from the skin to the thyroid isthmus (DSTI) in Thai patients undergoing elective surgery under general anesthesia. METHODS: In total, 189 patients who underwent general anesthesia during elective surgery were enrolled in this prospective cohort observational study. Pre-operative physical examinations and airway evaluations were performed as usual. Airway ultrasound was performed to measure DSHB and DSTI before the anesthetic procedure. Anesthesiologists and nurse anesthetists performed bag-and-mask ventilation. DMV was assessed and recorded according to Han's mask ventilation classification in which DMV-0 indicates no attempt at mask ventilation; DMV-I indicates successful ventilation by mask; DMV-II indicates ventilation by mask with oral airway/adjuvant ventilation; DMV-III indicates that ventilation required two providers; and DMV-IV indicates the patient's inability to undergo mask ventilation. RESULTS: Thirty (17%) patients were classified as having DMV-0, and DMV-I, II, and III classifications were observed in 126(67%), 18(10%), and 12(6%) patients, respectively. None of the patients were classified as DMV-IV. The DSHB medians were 0.4(0.3-0.6), 0.7(0.5-1), 0.7(0.6-0.8), and 0.6(0.3-0.9) cm in DMV-0, I, II, and III, respectively (p < 0.001). The DSTI medians were 0.9(0.8-1.1), 0.8(0.7-1.1), 0.7(0.6-0.9), and 0.8(0.8-1.4) cm for DMV-0, I, II, and III, respectively (p = 0.041). Multivariate logistic regression indicated that the following factors were associated with difficult mask ventilation (DMV-III): male sex, modified Mallampati classification III, edentulousness, DSHB, and DSTI, with an area under the curve of 0.89. CONCLUSIONS: This study showed that airway ultrasonography to determine DSHB and DSTI during patients' routine physical examinations significantly improved the prediction of DMV. Patients classified as having DMV-III require prompt management for airway difficulties. However, the individual factors DSHB and DSTI alone are insufficient to predict DMV. TRIAL REGISTRATION: Registration number: TCTR2020093002.